Stockscreener 앱 받기
17.36
3.95%
0.66
시간 외 거래:
17.42
0.06
+0.35%
Adaptive Biotechnologies Corp 주식(ADPT)의 최신 뉴스
Adaptive Biotechnologies (ADPT) shareholders back directors, pay and 2026 auditor - Stock Titan
Adaptive Biotechnologies CCO Bobulsky sells $198,000 in stock By Investing.com - Investing.com India
Adaptive Biotechnologies CPO Francis Lo sells $695k in stock By Investing.com - Investing.com India
Adaptive Biotechnologies (ADPT) CPO sells 39,741 shares after option exercises - Stock Titan
Adaptive Biotechnologies CPO Francis Lo sells $695k in stock - Investing.com
Adaptive Biotechnologies CCO Bobulsky sells $198,000 in stock - Investing.com
[144] Adaptive Biotechnologies Corp SEC Filing - Stock Titan
ADPT (NASDAQ: ADPT) affiliate notifies planned sale after option exercise - Stock Titan
How The Adaptive Biotechnologies (ADPT) Narrative Is Shifting Around A US$20 Fair Value Anchor - Yahoo Finance
Adaptive Biotechnologies Highlights clonoSEQ Growth, 2026 Cash Flow Goal at Conference - Barchart.com
Adaptive Biotech (ADPT) Reports 35% Revenue Growth Driven by Strong clonoSEQ Performance in Q1 2026 - Insider Monkey
10 Best Growth Stocks Under $20 to Buy - Insider Monkey
Does ADPT’s clonoSEQ Spotlight at ASCO and EHA Reveal a Durable MRD Moat in Oncology? - simplywall.st
Jupiter Asset Management Ltd. Acquires 91,683 Shares of Adaptive Biotechnologies Corporation $ADPT - MarketBeat
Adaptive Biotechnologies Hits Day High with 9.75% Surge in Stock Price - MarketsMojo
Adaptive Biotechnologies Announces Extensive Presence at ASCO and EHA Conferences Showcasing clonoSEQ Test for MRD Assessment - Quiver Quantitative
Blood cancer monitoring test featured in 33 studies at major oncology meetings - Stock Titan
Harvest Investment Services Dumps 356,000 Adaptive Biotechnologies (ADPT) Shares Worth $5.7 Million - AOL.com
Harvest Investment Services Dumps 356,000 Adaptive Biotechnologies (ADPT) Shares Worth $5.7 Million - The Motley Fool
ADPT SEC FilingsAdaptive Biotechnologies 10-K, 10-Q, 8-K Forms - Stock Titan
Hear Adaptive Biotechnologies' June 3 investor talk live online - Stock Titan
Adaptive Biotechnologies to Participate in Upcoming Investor Conferences - The Manila Times
Adaptive Biotechnologies CFO Kyle Piskel sells $40,619 in stock By Investing.com - Investing.com Canada
Adaptive Biotechnologies CFO Kyle Piskel sells $40,619 in stock - Investing.com
Adaptive Biotechnologies (ADPT) CFO tax-related share sale leaves 256,725 shares held - Stock Titan
UBS Group AG Purchases 257,947 Shares of Adaptive Biotechnologies Corporation $ADPT - MarketBeat
Adaptive Biotechnologies Corp at TD Cowen Healthcare Conference Transcript - GuruFocus
Proposed sale of 3,160 RSUs by ADPT (NASDAQ: ADPT) reported - Stock Titan
Viking firms hold 18.8% of Adaptive Biotechnologies (NASDAQ: ADPT) - Stock Titan
ADPT Stock Price, Quote & Chart | ADAPTIVE BIOTECHNOLOGIES (NASDAQ:ADPT) - ChartMill
ADPT Maintained by Morgan Stanley -- Price Target Lowered to $18 - GuruFocus
Morgan Stanley Cuts Adaptive Biotechnologies (NASDAQ:ADPT) Price Target to $18.00 - MarketBeat
Assessing Adaptive Biotechnologies (ADPT) Valuation After Strong MRD Growth And Raised Full Year Guidance - Yahoo Finance
Analysts Expect Breakeven For Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Before Long - Moomoo
How Strong MRD Growth and Upgraded 2026 Guidance Will Impact Adaptive Biotechnologies (ADPT) Investors - simplywall.st
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q1 2026 Earnings Call Transcript - Insider Monkey
Adaptive Biotech Q1 2026 slides: MRD revenue surges 53%, guidance raised - Investing.com Australia
Adaptive Biotechnologies Corporation 10-Q Report 2026: Financial Statements, Risk Factors, and Forward-Looking Statements 173031 - Minichart
Adaptive Biotech Q1 2026 slides: MRD revenue surges 53%, guidance raised By Investing.com - Investing.com South Africa
Earnings call transcript: Adaptive Biotechnologies Q1 2026 revenue beats forecast By Investing.com - Investing.com South Africa
Adaptive Biotechnologies (ADPT) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
3.71%
자본화:
|
볼륨(24시간):